Comparison of the prognoses of figo stage i to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy

International Journal of Gynecological Cancer

Volumn 22, Issue 8, 2012, Pages 1389-1397

  Mabuchi, Seiji ^a   Okazawa, Mika ^a,b   Kinose, Yasuto ^a   Matsuo, Koji ^c   Fujiwara, Masateru ^a   Suzuki, Osamu ^b   Morii, Eiichi ^a   Kamiura, Shoji ^b   Ogawa, Kazuhiko ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adenocarcinoma; Adenosquamous carcinoma; Cervical cancer; Radical hysterectomy; Survival

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84867250777     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31826b5d9b     Document Type: Article

References (31)

1. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100:1035-1044.
2. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535-540.
3. DelgadoG,BundyB, ZainoR, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352-357.
4. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999;73:175-176.
5. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
6. Cherry CP, Glucksmann A. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer. 1956;9:971-979.
7. Gallup DG, Harper RH, Stock RJ. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix. Obstet Gynecol. 1985;65:416-422.
8. Hopkins MP, Schmidt RW, Roberts JA, et al. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol. 1988;72:915-921.
9. Kilgore LC, Soong SJ, Gore H, et al. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol. 1988;31:137-153.
10. Goodman HM, Buttlar CA, Niloff JM, et al. Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol. 1989;33:241-247.
11. Yazigi R, Sandstad J, Munoz AK, et al. Adenosquamous carcinoma of the cervix: prognosis in stage IB. Obstet Gynecol. 1990;75:1012-1015.
12. Harrison TA, Sevin BU, Koechli O, et al. Adenosquamous carcinoma of the cervix: prognosis in early-stage disease treated by radical hysterectomy. Gynecol Oncol. 1993;50:310-315.
13. Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995;76:1948-1955.
14. Look KY, Brunetto VL, Clarke-Pearson DL, et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1996;63:304-311.
15. Lea JS, Coleman RL, Garner EO, et al. Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol. 2003;91:558-562.
16. Farley JH, Hickey KW, Carlson JW, et al. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003;97:2196-2202.
17. Alfsen GC, Kristensen GB, Skovlund E, et al. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer. 2001;92:2471-2483.
18. Yasuda S, Kojima A, Maeno Y, et al. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymph node metastasis. Kobe J Med Sci. 2006;52:9-15.
19. dos Reis R, Frumovitz M, Milam MR, et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007;107:458-463.
20. WHO. Tumours of the uterine cervix. In: Tavassoli FA, Stratton MR, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2002:259-289.
21. Mabuchi S, Morishige K, Isohashi F, et al. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol. 2009;115:482-487.
22. Mabuchi S, Okazawa M, Isohashi F, et al. Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases. Gynecol Oncol. 2011;120:94-100.
23. Mabuchi S, Okazawa M, Isohashi F, et al. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer. Gynecol Oncol. 2011;123:241-247.
24. Okazawa M, Mabuchi S, Isohashi F, et al. The prognostic significance of multiple pelvic node metastases in cervical cancer patients treated with radical hysterectomy plus adjuvant chemoradiotherapy. Int J Gynecol Cancer. 2012;22:490-497.
25. Mabuchi S, Kimura T. Nedaplatin: a radiosensitizing agent for patients with cervical cancer. Chemother Res Pract. 2011;2011:963159.
26. Mabuchi S, Isohashi F, Yoshioka Y, et al. Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy. Int J Gynecol Cancer. 2010;20:834-840.
27. Mabuchi S, Isohashi F, Maruoka S, et al. Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy. Arch Obstet Gynecol. 2012;286:176-185.
28. Regaud C, Gricouroff G. Sur la classification histogenetique des epitheliomas cervico-uterins, et particulièrement sur les epitheliomas pseudo-epidermiques, originaires de I'epithelium canalaire mucipaire. Bull Assoc Fr Etude Cancer. 1933;22:285-295.
29. Macdonald OK, Chen J, Dodson M, et al. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol. 2009;32:411-416.
30. Duenas-Gonzalez A, Zarba JJ, Patel F, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29:1678-1685.
31. Kitchener HC, Hoskins W, Small W Jr, et al Cervical Cancer Consensus Group. The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report. Int J Gynecol Cancer. 2010;20:1092-1100.